Table 1 Comparison of clinical characteristics between patients with or without neoadjuvant radiotherapy in the original dataset and in the propensity score matched dataset.

From: Population-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to age

Clinical Characters

Before Propensity Score Matching

After Propensity Score Matching

Sn (%)

Sn + PRT (%)

SD

Sn (%)

Sn + PRT (%)

SD

RACE

Withe

5304 (80.07)

4997 (80.90)

−0.0208

3996 (80.18)

3997 (80.20)

−0.0005

Black

596 (9.00)

504 (8.16)

0.0299

461 (9.25)

427 (8.57)

0.0239

Unknown

724 (10.93)

676 (10.94)

−0.0004

527 (10.57)

560 (11.24)

−0.0212

GENDER

Male

3576 (53.99)

3868 (62.62)

−0.1758

2961 (59.41)

3026 (60.71)

−0.0266

Female

3048 (46.01)

2309 (37.38)

 

2023 (40.59)

1958 (39.29)

 

AGE

< = 50

956 (14.43)

1555 (25.17)

−0.2720

956 (19.18)

1027 (20.61)

−0.0357

>50

5668 (85.57)

4622 (74.83)

 

4028 (80.82)

3957 (79.39)

 

TUMOR NUMBER

Single

6046 (91.27)

5757 (93.20)

−0.0720

4588 (92.05)

4608 (92.46)

−0.0150

Multiple

578 (8.73)

420 (6.80)

 

396 (7.95)

376 (7.54)

 

TUMOR SIZE

< = 5 cm

4250 (64.16)

4518 (73.14)

−0.1945

3467 (69.56)

3465 (69.52)

0.0009

>5 cm

2374 (35.84)

1659 (26.86)

 

1517 (30.44)

1519 (30.48)

 

TNM STAGE

II

2903 (43.83)

2647 (42.85)

0.0196

2133 (42.80)

2131 (42.76)

0.0008

III

3721 (56.17)

3530 (57.15)

 

2851 (57.20)

2853 (57.24)

 

HISTOLOGICAL TYPE

Non-mucinous

6234 (94.11)

5686 (92.05)

0.0813

4658 (93.46)

4585 (91.99)

0.0564

Mucinous

353 (5.33)

449 (7.27)

−0.0799

291 (5.84)

373 (7.48)

−0.0660

SRCC

37 (0.56)

42 (0.68)

−0.0155

35 (0.70)

26 (0.52)

0.0232

GRADE

Well

358 (5.40)

378 (6.12)

−0.0307

291 (5.84)

340 (6.82)

−0.0404

Moderately

5166 (77.99)

4878 (78.97)

−0.0239

3917 (78.59)

3881 (77.87)

0.0175

Poorly

992 (14.98)

827 (13.39)

0.0455

703 (14.11)

686 (13.76)

0.0098

undifferentiated

108 (1.63)

94 (1.52)

0.0087

73 (1.46)

77 (1.54)

−0.0066

LYMPH NODE

negative

91 (1.37)

310 (5.02)

−0.2083

91 (1.83)

168 (3.37)

−0.0972

< = 12

1224 (18.48)

2127 (34.43)

−0.3678

1181 (23.70)

1360 (27.29)

−0.0825

>12

5309 (80.15)

3740 (60.55)

0.4394

3712 (74.48)

3456 (69.34)

0.1145

  1. Sn: surgery only; Sn + PRT: pre-radiation treatment + surgery; SD: standardized difference; SRCC: sing-ring cell carcinoma.